Search Results 21-30 of 3189 for ������������������������������������:VB20��������������������� ������

  1. Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia - Mayo Clinic

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...

  2. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    The purpose of this study is to assess the safety, tolerability, pharmaokinetics, and preliminary effectiveness of mosunetuzumab in participants with relapsed ...

  3. ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 - Mayo Clinic

    The primary objective of this study is to evaluate the clinical effectiveness of different investigational therapeutics relative to the control arm in adults ...

  4. A Study to Evaluate AntiThrombotic Therapy to Lessen Complications of COVID-19 (Enrolling by Invitation Only) - Mayo Clinic

    The purpose of this study is to establish whether therapeutic-dose parenteral anticoagulation improves outcomes (reduces intubation or mortality) by 30 days ...

  5. Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer - Mayo Clinic

    About this study. This phase III clinical trial studies two different dose schedules of paclitaxel to see how well they work in combination with carboplatin ...

  6. A Study of Safety, Tolerability, Pharmacokinetic and Pharmacodynamics (PK/PD) in Patients With Hematologic Malignancies - Mayo Clinic

    A Study of Safety, Tolerability, Pharmacokinetic and Pharmacodynamics (PK/PD) in Patients With Hematologic Malignancies · More about research at Mayo Clinic.

  7. Role of VEGF Signaling in Vascular Permeability and the Zebrafish Disease Model - Tumor Angiogenesis and Vascular Biology Laboratory - Mayo Clinic Research

    The Mukhopadhyay Tumor Angiogenesis and Vascular Biology Lab at Mayo Clinic uses zebrafish models to study vascular permeability.

  8. Multi-Center Prospective Validation Study of VTE Risk Prediction Tool in Trauma Patients - Mayo Clinic

    Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease. Massive bleeding from injury ...

  9. A Study to Establish a Registry of Deep Brain Stimulation with the VERCISE™ System - Mayo Clinic

    The purpose of this study is to document characteristics of real-world outcomes for Boston Scientific Corporation's commercially approved Vercise™ System for ...

  10. Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma - Mayo Clinic

    About this study. This phase II trial studies how well vemurafenib and cobimetinib work in treating patients with BRAF V600E mutation positive ...